Distribution of the Major Cytochrome P450 (CYP) 2C9 Genetic Variants in a Saudi Population

被引:12
作者
Mirghani, Rajaa A. [1 ]
Chowdhary, Gulnaz [1 ]
Elghazali, Gehad [1 ,2 ,3 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Fac Med, King Fahad Med City, Riyadh 11393, Saudi Arabia
[2] King Fahad Med City, Dept Immunol, Riyadh, Saudi Arabia
[3] Univ Shendi, Fac Med & Hlth Sci, Shendi, Sudan
关键词
MUTANT ALLELES; P4502C9; POLYMORPHISMS; CYP2C19; PHARMACOKINETICS; FREQUENCIES; OXIDATION; GENOTYPES; LOSARTAN; WARFARIN;
D O I
10.1111/j.1742-7843.2011.00692.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (CYP) 2C9 is responsible for the metabolism of a number of widely used drugs such as oral anticoagulants, oral antidiabetics and non-steroidal anti-inflammatory drugs. The CYP2C9 is a genetically polymorphic enzyme. The most common allele is CYP2C9*1, while CYP2C9*2 and CYP2C9*3 are the less-frequent variants. The activity of the enzyme encoded by either CYP2C9 *2 or *3 variant is lower compared with that of the CYP2C9*1. The metabolism of most of the CYP2C9 substrates decreases in varying degrees in subjects carrying the CYP2C9 *2 or *3 allele. The aim of this study was to investigate the frequencies of the major variants of the CYP2C9 in Saudi Arabians.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 50 条
  • [31] Genotype–phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region
    Ekta Varshney
    Nilanjan Saha
    Monika Tandon
    Vikesh Shrivastava
    Shakir Ali
    European Journal of Drug Metabolism and Pharmacokinetics, 2013, 38 : 275 - 282
  • [32] Genetic Polymorphisms of Cytochrome p450 (2C9) Enzyme in Patients with Type 2 Diabetes Mellitus in Turkmen and Fars Ethnic Groups
    Rabiee, Mina
    Marjani, Abdoljalal
    Khajeniazi, Safoura
    Mojerloo, Mohammad
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (06) : 653 - 661
  • [33] Effects of Mace and Nutmeg on Human Cytochrome P450 3A4 and 2C9 Activity
    Kimura, Yuka
    Ito, Hideyuki
    Hatano, Tsutomu
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (12) : 1977 - 1982
  • [34] In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine
    Hung, Tzu-Chieh
    Kuo, Chia-Chen
    Chen, Calvin Yu-Chian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [35] In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9
    Iwasaki, Kazuhide
    Kitsugi, Yusuke
    Ikeda, Kanami
    Yoshikawa, Takahiro
    Hosaka, Shinya
    Uehara, Shotaro
    Uno, Yasuhiro
    Utoh, Masahiro
    Yamazaki, Hiroshi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2016, 37 (06) : 379 - 383
  • [36] Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population
    Buzkova, Helena
    Pechandova, Kristina
    Danzig, Vilem
    Vareka, Tomas
    Perlik, Frantisek
    Zak, Ales
    Slanar, Ondrej
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : CR512 - CR517
  • [37] Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region
    Varshney, Ekta
    Saha, Nilanjan
    Tandon, Monika
    Shrivastava, Vikesh
    Ali, Shakir
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2013, 38 (04) : 275 - 282
  • [38] Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
    Lim, Sharoen Yu Ming
    Al Bishtawi, Basel
    Lim, Willone
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (03) : 221 - 240
  • [39] Comparison in the In Vitro Inhibitory Effects of Major Phytocannabinoids and Polycyclic Aromatic Hydrocarbons Contained in Marijuana Smoke on Cytochrome P450 2C9 Activity
    Yamaori, Satoshi
    Koeda, Kyoko
    Kushihara, Mika
    Hada, Yui
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (03) : 294 - 300
  • [40] Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity
    Shadle, CR
    Lee, Y
    Majumdar, AK
    Petty, KJ
    Gargano, C
    Bradstreet, TE
    Evans, JK
    Blu, RA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (03) : 215 - 223